Arcutis Biotherapeutics Inc (ARQT) — Capital Reinvestment Ratio

Latest as of June 2026: 0.01x

Arcutis Biotherapeutics Inc (ARQT) has a Capital Reinvestment Ratio of 0.01x as of June 2026, meaning it reinvests 0% of its operating cash flow ($12.64 Million) in capital expenditures ($158.00K). Check ARQT tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$12.64 Million

USD

Capital Expenditures

$158.00K

USD

Data as of

Jun 2026

Most recent filing

Annual Capital Reinvestment Ratio for Arcutis Biotherapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Arcutis Biotherapeutics Inc from None to None. See cash generation quality of Arcutis Biotherapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow